Patents by Inventor William Trigg

William Trigg has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9220795
    Abstract: An indole-based in vivo imaging agent is provided by the present invention that binds with high affinity to PBR, has good uptake into the brain following administration, and which has good selective binding to PBR. The invention also includes a precursor compound useful in the synthesis of the in vivo imaging agent of the invention, as well as a method for synthesis of said in vivo imaging agent comprising use of said precursor compound, and a kit for carrying out said method. Also provided is a cassette for automated synthesis of the in vivo imaging agent. Further aspects of the invention include a radiopharmaceutical composition comprising the in vivo imaging agent of the invention, and methods for the use of said in vivo imaging agent.
    Type: Grant
    Filed: June 9, 2014
    Date of Patent: December 29, 2015
    Assignee: GE Healthcare Limited
    Inventors: Harry John Wadsworth, Dennis O'Shea, Joanna Passmore, William Trigg, Amanda Eewan, Bo Shan
  • Patent number: 8946410
    Abstract: The present invention provides a method to obtain radiofluorinated compounds useful for in vivo imaging GABAA receptors. The method of the invention is high-yielding and may conveniently be carried out on an automated synthesizer such as Fastlabâ„¢. A further aspect of the invention is a cassette suitable for carrying out the automated method of synthesis of the invention. Novel precursor compounds useful in the method of the invention are also provided, as are a number of novel compounds obtained by the method of the invention.
    Type: Grant
    Filed: October 8, 2010
    Date of Patent: February 3, 2015
    Assignee: GE Healthcare Limited
    Inventors: John Woodcraft, L Clare Jones, Alessandra Gaeta, John William Trigg, Alexander Paul Jones, Stuart Plant, Alexander Jackson
  • Publication number: 20140364615
    Abstract: An indole-based in vivo imaging agent is provided by the present invention that binds with high affinity to PBR, has good uptake into the brain following administration, and which has good selective binding to PBR. The invention also includes a precursor compound useful in the synthesis of the in vivo imaging agent of the invention, as well as a method for synthesis of said in vivo imaging agent comprising use of said precursor compound, and a kit for carrying out said method. Also provided is a cassette for automated synthesis of the in vivo imaging agent. Further aspects of the invention include a radiopharmaceutical composition comprising the in vivo imaging agent of the invention, and methods for the use of said in vivo imaging agent.
    Type: Application
    Filed: June 9, 2014
    Publication date: December 11, 2014
    Applicant: GE HEALTHCARE LIMITED
    Inventors: HARRY JOHN WADSWORTH, DENNIS O'SHEA, JOANNA PASSMORE, WILLIAM TRIGG, AMANDA EWAN, BO SHAN
  • Publication number: 20120190843
    Abstract: The present invention provides a method to obtain radiofluorinated compounds useful for in vivo imaging GABAA receptors. The method of the invention is high-yielding and may conveniently be carried out on an automated synthesizer such as Fastlabâ„¢. A further aspect of the invention is a cassette suitable for carrying out the automated method of synthesis of the invention. Novel precursor compounds useful in the method of the invention are also provided, as are a number of novel compounds obtained by the method of the invention.
    Type: Application
    Filed: October 8, 2010
    Publication date: July 26, 2012
    Inventors: John Woodcraft, L. Clare Jones, Alessandra Gaeta, John William Trigg, Alexander Paul Jones, Stuart Plant, Alexander Jackson
  • Publication number: 20050256151
    Abstract: Compounds which are pyrrolo[2,3-b]pyridine derivatives or pharmaceutically acceptable salts thereof, their preparation process and pharmaceutical compositions comprising them are disclosed; these compounds are useful in the treatment of diseases caused by and/or associated with an altered protein kinase activity such as cancer, cell proliferative disorders, Alzheimer's disease, viral infections, auto-immune diseases and neurodegenerative disorders; also disclosed is a process under SPS conditions for preparing the compounds of the invention and chemical libraries comprising a plurality of them.
    Type: Application
    Filed: December 23, 2004
    Publication date: November 17, 2005
    Applicant: Pharmacia Italia S.p.A.
    Inventors: Barbara Salom, Matteo D'Anello, Maria Brasca, Patrizia Giordano, Katia Martina, Francesco Angelucci, Frederick Brookfield, William Trigg, Edward Boyd, Jonathan Larard
  • Publication number: 20050209269
    Abstract: Compounds which are pyrrolo[2,3-b]pyridine derivatives or pharmaceutically acceptable salts thereof, their preparation process and pharmaceutical compositions comprising them are disclosed; these compounds are useful in the treatment of diseases caused by and/or associated with an altered protein kinase activity such as cancer, cell proliferative disorders, Alzheimer's disease, viral infections, auto-immune diseases and neurodegenerative disorders; also disclosed is a process under SPS conditions for preparing the compounds of the invention and chemical libraries comprising a plurality of them.
    Type: Application
    Filed: December 23, 2004
    Publication date: September 22, 2005
    Applicant: Pharmacia Italia S.p.A.
    Inventors: Barbara Salom, Matteo D'Anello, Maria Brasca, Patrizia Giordano, Katia Martina, Dania Tesei, Frederick Brookfield, William Trigg, Edward Boyd, Jonathan Larard